S&P Global Inc. (SPGI34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 66.44 |
|---|---|
| 52-week range | 52.26 – 82.60 |
| Return, 1 month / 3 months | +14.2% / +7.1% |
| Return, 1 year / 3 years | −9.4% / +42.4% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 39.9% |
| Worst drawdown (1 year) | -33.6% |
| Average daily value traded | 0.14M BRL |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
S&P Global Inc. is a provider of credit ratings, benchmarks and analytics for the financial markets. Through its ratings business it assesses the creditworthiness of issuers and debt instruments, while its market intelligence arm supplies data and research to investors and corporations. It also operates commodity pricing services and publishes widely followed equity indices. The company is based in the United States and serves customers around the world.
S&P Global Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code SPGI34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
S&P Global Inc. (SPGI34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 66.44 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 782 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.4% and over the last three months it rose 7.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -19.2% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 7.1% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | -20.7% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.6% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.14M BRL | ||
| Zero-volume days | 1.7% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +8.7% |
|---|---|
| 1 month | +14.2% |
| 3 months | +7.1% |
| 6 months | +10.2% |
| 1 year | −9.4% |
| 3 years | +42.4% |
| 5 years | −3.6% |
Signals
| 50-day / 200-day average | 60.23 / 61.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Aug 2026 | USD 0.0943 |
| 27 May 2026 | USD 0.0938 |
| 23 Feb 2026 | USD 0.0949 |
| 21 Nov 2025 | USD 0.1936 |
| 22 Aug 2025 | USD 0.0971 |
| 26 May 2025 | USD 0.0999 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.